rafa-logo.png
Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University
11 déc. 2023 09h30 HE | Rafarma Pharmaceuticals Inc.
Sheridan, Wyoming, USA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - We are pleased to announce that Rapharma and its CEO Raivo Unt have entered into a preliminary agreement...
rafa-logo.png
Rafarma Pharmaceutical news update
30 nov. 2023 09h30 HE | Rafarma Pharmaceuticals Inc.
Russia, Moscow, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA). The Company is pleased to announce that it has completed the restructuring, accounting and balance sheet...
Logo.png
Rafarma Pharmaceuticals strengthens its position in Central Asia
29 avr. 2022 09h15 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, April 29, 2022 (GLOBE NEWSWIRE) -- Representatives of Rafarma Pharmaceuticals, Inc. (OTC: RAFA) visited Uzbekistan and discussed the prospects for the company's development in the...
LOGO.png
Rafarma’s Slavich Noya Technology Division Expands Printing Production
07 févr. 2022 09h15 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) Slavich Noya Technology, part of the Rafarma Pharmaceuticals group of companies, is expanding its...
LOGO.png
RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research
21 déc. 2021 10h50 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is currently negotiating with the Joint Institute for Nuclear Research (JINR), an international...
LOGO.png
Explosive Growth Launches Kraspharma Into REMEDIUM TOP-5
19 nov. 2021 09h25 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) reports that PJSC Kraspharma at the end of 2020 entered the TOP-5 of the most dynamic and largest...
LOGO.png
Status Update to Shareholders from Rafarma Pharmaceuticals, Inc.
08 nov. 2021 10h43 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) provides the following update to shareholders: The company is continuing its PCAOB auditing process, and,...
LOGO.png
Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs
19 août 2021 10h25 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and one of the world's largest producers of precious metals, Krastsvetmet (Russia, Krasnoyarsk), discussed...
LOGO.png
Rafarma Signs Trilateral Investment Agreement Officially Launching Tashkent Pharmaceutical Plant Build
30 juil. 2021 09h49 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, July 30, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) The scientific and technical council of the Agency for the Development of the Pharmaceutical Industry of...
LOGO.png
Rafarma’s Global Pharmaceutical Strategy At A Glance
18 mai 2021 08h53 HE | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, May 18, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is an international biotechnological and pharmaceutical company that combines research centers and modern...